[
    [
        {
            "time": "2021-10-28",
            "original_text": "财联社10月28日电，上海医药公告，以不超过2.925亿美元（除销售提成外）的交易金额将具有自主知识产权的SPH6162在中国区域（包括香港、澳门及台湾）以外的制造、使用、销售、进口、开发及商业化权利许可给HU_YABIO。",
            "features": {
                "keywords": [
                    "上海医药",
                    "SPH6162",
                    "知识产权",
                    "海外权益",
                    "许可协议"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "财联社10月28日电，上海医药公告，以不超过2.925亿美元（除销售提成外）的交易金额将具有自主知识产权的SPH6162在中国区域（包括香港、澳门及台湾）以外的制造、使用、销售、进口、开发及商业化权利许可给HU_YABIO。",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "16万股东无眠！云南白药炒股巨亏11亿，股价应声大跌 投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股亏损",
                    "投资失误",
                    "股价下跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "16万股东无眠！云南白药炒股巨亏11亿，股价应声大跌 投资失误",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "License-in再下一城 上海医药拟不超1.07亿美元引进KBioLabs两款益生菌新药",
            "features": {
                "keywords": [
                    "上海医药",
                    "License-in",
                    "益生菌新药",
                    "KBioLabs"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "License-in再下一城 上海医药拟不超1.07亿美元引进KBioLabs两款益生菌新药",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "16万股民今夜无眠！炒股浮亏超11亿 千亿大白马云南白药暴雷 投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股浮亏",
                    "投资失误",
                    "股价波动"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "16万股民今夜无眠！炒股浮亏超11亿 千亿大白马云南白药暴雷 投资失误",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "云南白药2021年三季报点评：主营稳健增长 多元化模式开拓研发创新",
            "features": {
                "keywords": [
                    "云南白药",
                    "三季报",
                    "主营增长",
                    "研发创新"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "云南白药2021年三季报点评：主营稳健增长 多元化模式开拓研发创新",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]